CardiaTec leverages human multiomics data to navigate complex disease biology and identify novel therapeutics for cardiovascular diseases. The platform analyzes multi-omic data to discover differentiated drug targets. Founded in 2021 in Cambridge, United Kingdom, the company has raised $10.9M in seed funding from investors including Laidlaw Scholars Ventures, APEX Ventures, Crista Galli Ventures, Cambridge Enterprise, and Montage Ventures. Provider of novel therapeutic discovery platform for cardiovascular diseases. The company leverages human multiomics data to navigate complex disease biology to identify novel and differentiated therapeutics for cardiovascular diseases. Founded in 2021, headquartered in Cambridge, United Kingdom. The team comprises 17 (Jun 30, 2026) employees. Backed by investors including Laidlaw Scholars Ventures, APEX Ventures, Crista Galli Ventures,.
← All startups
CardiaTec
SeedCardiaTec leverages human multiomics data to navigate complex disease biology and identify novel therapeutics for cardiovascular diseases. The platform analyzes multi-omic data to discover differentiated drug targets. Founded in 2021 in Cambridge, United Kingdom, the company has raised $10.9M in seed funding from investors including Laidlaw Scholars Ventures, APEX Ventures, Crista Galli Ventures, Cambridge…
About
Business model
Life Sciences Tech > Research & Development > Drug Discovery > Cheminformatics > Lead Discovery > AI Based
Team background
College Wise > University of Cambridge, York University
Institutional investors
Laidlaw Scholars VenturesAPEX VenturesCrista Galli Ventureso2h venturesCambridge EnterpriseMontage VenturesContinuum Health VenturesLQD VCZentynelSF500Time PartnersCambridge AngelsUniversity of CambridgePlug and Play Tech CenterNaheed Kurji
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.